MA (EU) number 
EU/1/07/422/001 
(Invented) 
name 
Tasigna 
Strength  Pharmaceutical 
Form 
Capsule, hard 
200 mg 
Route of 
Administration 
Oral use 
EU/1/07/422/003 
Tasigna 
200 mg 
Capsule, hard 
Oral use 
EU/1/07/422/005 
Tasigna 
150 mg 
Capsule, hard 
Oral use 
EU/1/07/422/006 
Tasigna 
150 mg 
Capsule, hard 
Oral use 
EU/1/07/422/007 
Tasigna 
200 mg 
Capsule, hard 
Oral use 
EU/1/07/422/008 
Tasigna 
200 mg 
Capsule, hard 
Oral use 
EU/1/07/422/009 
Tasigna 
150 mg 
Capsule, hard 
Oral use 
EU/1/07/422/010 
Tasigna 
150 mg 
Capsule, hard 
Oral use 
EU/1/07/422/011 
Tasigna 
200 mg 
Capsule, hard 
Oral use 
EU/1/07/422/012 
Tasigna 
200 mg 
Capsule, hard 
Oral use 
EU/1/07/422/013 
Tasigna 
150 mg 
Capsule, hard 
Oral use 
EU/1/07/422/014 
Tasigna 
200 mg 
Capsule, hard 
Oral use 
EU/1/07/422/015 
Tasigna 
50 mg 
Capsule, hard 
Oral use 
Immediate Packaging 
Pack size 
Blister (PVC/PVDC/Alu); 
wallet 
Blister (PVC/PVDC/Alu); 
wallet 
Blister (PVC/PVDC/Alu); 
carton 
Blister (PVC/PVDC/Alu); 
carton 
Blister (PVC/PVDC/Alu); 
carton 
Blister (PVC/PVDC/Alu); 
carton 
Blister (PVC/PVDC/Alu); 
carton 
Blister (PVC/PVDC/Alu); 
carton 
Blister (PVC/PVDC/Alu); 
carton 
Blister (PVC/PVDC/Alu); 
carton 
Blister (PVC/PVDC/Alu); 
carton 
Blister (PVC/PVDC/Alu); 
carton 
Blister (PVC/PVDC/Alu); 
carton 
28 capsules 
112 (4x28) capsules 
(multipack) 
28 capsules 
112 (4x28) capsules 
(multipack) 
28 capsules 
112 (4x28) capsules 
(multipack) 
40 capsules 
120 (3x40) capsules 
(multipack) 
40 capsules 
120 (3x40) capsules 
(multipack) 
392 (14x28) capsules 
(multipack) 
392 (14x28) capsules 
(multipack) 
120 (3x40) capsules 
1/1 
 
 
 
